Walkley S U, Thrall M A, Haskins M E, Mitchell T W, Wenger D A, Brown D E, Dial S, Seim H
Department of Neuroscience, Rose F. Kennedy Center for Research in Mental Retardation and Human Development, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Neuropathol Appl Neurobiol. 2005 Oct;31(5):536-44. doi: 10.1111/j.1365-2990.2005.00675.x.
Mucopolysaccharidosis (MPS) type VI, also known as Maroteaux-Lamy disease, is an inherited disorder of glycosaminoglycan catabolism caused by deficient activity of the lysosomal hydrolase, N-acetylgalactosamine 4-sulphatase (4S). A variety of prominent visceral and skeletal defects are characteristic, but primary neurological involvement has generally been considered absent. We report here that the feline model of MPS VI exhibits abnormal lysosomal storage in occasional neurones and glia distributed throughout the cerebral cortex. Abnormal lysosomal inclusions were pleiomorphic with some resembling zebra bodies and dense core inclusions typical of other MPS diseases or the membranous storage bodies characteristic of the gangliosidoses. Pyramidal neurones were shown to contain abnormal amounts of GM2 and GM3 gangliosides by immunocytochemical staining and unesterified cholesterol by histochemical (filipin) staining. Further, Golgi staining of pyramidal neurones revealed that some possessed ectopic axon hillock neurites and meganeurites similar to those described in Tay-Sachs and other neuronal storage diseases with ganglioside storage. Some animals evaluated in this study also received allogeneic bone marrow transplants, but no significant differences in neuronal storage were noted between treated and untreated individuals. These studies demonstrate that deficiency of 4S activity can lead to metabolic abnormalities in the neurones of central nervous system in cats, and that these changes may not be readily amenable to correction by bone marrow transplantation. Given the close pathological and biochemical similarities between feline and human MPS VI, it is conceivable that children with this disease have similar neuronal involvement.
VI型黏多糖贮积症(MPS),也称为马罗-拉米病,是一种由于溶酶体水解酶N-乙酰半乳糖胺4-硫酸酯酶(4S)活性缺乏引起的糖胺聚糖分解代谢的遗传性疾病。其特征是出现多种明显的内脏和骨骼缺陷,但一般认为不存在原发性神经受累。我们在此报告,MPS VI的猫模型在分布于整个大脑皮层的偶发神经元和神经胶质细胞中表现出异常的溶酶体贮积。异常的溶酶体包涵体形态多样,有些类似于斑马体和其他MPS疾病典型的致密核心包涵体,或神经节苷脂病特征性的膜性贮积体。通过免疫细胞化学染色显示,锥体神经元含有异常量的GM2和GM3神经节苷脂,通过组织化学(制霉菌素)染色显示含有未酯化胆固醇。此外,锥体神经元的高尔基染色显示,有些神经元具有异位轴丘神经突和巨神经突,类似于在泰-萨克斯病和其他伴有神经节苷脂贮积的神经元贮积病中所描述的。在本研究中评估的一些动物还接受了同种异体骨髓移植,但在治疗和未治疗的个体之间未发现神经元贮积有显著差异。这些研究表明,4S活性缺乏可导致猫中枢神经系统神经元的代谢异常,并且这些变化可能不易通过骨髓移植得到纠正。鉴于猫和人类MPS VI在病理和生化方面有密切相似性,可以设想患有这种疾病的儿童有类似的神经元受累情况。